4th Quarter - Amendment — ALLERGAN USA, INC. for ALLERGAN USA, INC. (2008)

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm

ALLERGAN USA, INC.

Client

ALLERGAN USA, INC.

Income

—

Expenses

$180,000

Expense method

A: Lobbying Disclosure Act definitions

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing	Filed	Amount	Counted
4th Quarter - Report	Jan 15, 2009	—	Replaced
4th Quarter - Amendment (this page)	Jan 15, 2009	$180,000	Replaced
4th Quarter - Amendment	Apr 27, 2009	$150,000	Yes

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Copyright/Patent/Trademark CPT

H.R.1908, S.1145 Patent Reform Act of 2007 H.R.806 To Amend the FD&C Act to Prohibit the Marketing of Authorized Generics S.438 Fair Prescription Drug Competition Act H.R.1038, S.623 Access to Life Saving Medicines Act H.R.1956 Patient Protection and Innovative Biologic Medicines Act of 2007 H.R.5629 Pathway for Biosimilars Act H.R.1902 Protecting Consumers Access to Generic Drugs Act of 2007 S.316 Preserve Access to Affordable Generics Act

Lobbyist	Covered position, as disclosed
G THOMAS LONG	—
ASHLIE VAN METER New	—

Contacted: Centers For Medicare and Medicaid Services (CMS); SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 1956 (110th), H.R. 1902 (110th), S. 623 (110th), H.R. 5629 (110th), S. 1145 (110th), S. 438 (110th), H.R. 1038 (110th), S. 316 (110th), H.R. 1908 (110th), H.R. 806 (110th)

Budget/Appropriations BUD

Agriculture Appropriations for FY 2009: FDA (OGD) Deficit Reduction Act (P.L. 109-171): Medicare and Medicaid Provisions

Lobbyist	Covered position, as disclosed
G THOMAS LONG	—
ASHLIE VAN METER New	—

Contacted: HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); SENATE

Medicare/Medicaid MMM

S.1951/H.R.3700 Fair Medicaid Drug Payment Act H.R.3140 Saving our Community Pharmacies Act H.R.3191 Access to Community Pharmacy Preservation Act Medicare Improvement for Patients & Providers Act of 2008 (P.L. 110-275)

Lobbyist	Covered position, as disclosed
G THOMAS LONG	—
ASHLIE VAN METER New	—

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS)

Bills named: H.R. 3191 (110th), H.R. 3140 (110th), H.R. 3700 (110th), S. 1951 (110th)

Health Issues HCR

S.1082 Prescription Drug User Fee Amendments of 2007 H.R.2716 Reducing Fraudulant and Imitative Drugs Act of 2007 S.242/S.251 Pharmaceutical Marketing Access Act of 2007 The Prescription Drug Marketing Act and various other bills and amendments relating to anti-counterfeiting/pedigree issues. H.R.5839 Safeguarding America's Pharmaceuticals Act of 2008 Various bill and amendments relating to drug importation The Food and Drug Amendments Act of 2007 H.R.3610 Food and Drug Import Safety Act of 2007 Various bills and amendments relating to drug safety and inspection of foreign drug manufacturing facilities.

Lobbyist	Covered position, as disclosed
G THOMAS LONG	—
ASHLIE VAN METER New	—

Contacted: Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 5839 (110th), H.R. 2716 (110th), S. 1082 (110th), H.R. 3610 (110th), S. 242 (110th), S. 251 (110th)

Medical/Disease Research/Clinical Labs MED

H.R.1193/S.691 Kidney Care Quality and Education Act of 2007

Lobbyist	Covered position, as disclosed
G THOMAS LONG	—
ASHLIE VAN METER New	—

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Centers For Medicare and Medicaid Services (CMS)

Bills named: H.R. 1193 (110th), S. 691 (110th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.